Last reviewed · How we verify
Ascites
Approved treatments
- Spironolacton · ACS Biomarker
- Aldactone · Generic (originally Searle/Pfizer)
Potassium-sparing diuretic and mineralocorticoid receptor antagonist that blocks aldosterone, reducing fluid retention and lowering blood pressure. - spirolactone · Second Xiangya Hospital of Central South University
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Ascites patent landscape — cliff calendar, originator estates, attackable patents
- Ascites treatment landscape brief
- Ascites treatment updates RSS
Frequently asked questions about Ascites
What drugs treat Ascites?
Tracked treatments include Spironolacton, Aldactone, spirolactone.
What is the treatment for Ascites?
Standard treatment for Ascites includes Spironolacton, Aldactone, spirolactone. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Ascites patent cliff · Ascites CI report
- Treatment: Spironolacton · ACS Biomarker
- Treatment: Aldactone · Generic (originally Searle/Pfizer)
- Treatment: spirolactone · Second Xiangya Hospital of Central South University
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing